Evidence map›Paper›PMID 34468231›Full record

SynthesisCancer control : journal of the Moffitt Cancer Center

Association Between

Huiqin Guo, Yuxiang Liao, Ao Lin, Huiran Lin, Xiaokai Huang, Jichen Ruan, Li Yuan, Zhenjian Zhuo

Open access · goldAbstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Disease markers · 2022
    Article
  3. Genetic Variations ofPharmacogenomics and personalized medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Huiqin GuoSchool of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Yuxiang LiaoDepartment of Neurosurgery, 159374Xiangya Hospital, Central South University, Changsha, Changsha, China.
Ao LinDepartment of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, 159390Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.
Huiran LinFaculty of Medicine, 58816Macau University of Science and Technology, Macau, China.
Xiaokai HuangDepartment of Hematology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jichen RuanDepartment of Hematology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Li YuanDepartment of Pathology, 159390Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.
Zhenjian ZhuoSchool of Medicine, South China University of Technology, Guangzhou, Guangdong, China.ORCID https://orcid.org/0000-0003-0142-4086
Guangzhou Women and Children Medical Center · CNWenzhou Medical University · CNCentral South University · CNMacau University of Science and Technology · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gliomas are the most prevalent brain tumors among children and adolescents. The occurrence and development of various malignant tumors is closely related with

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideBiomarkers, TumorBrain NeoplasmsChildChinaDNA, NeoplasmGenotypeGliomaHumansNeoplasm StagingRNA-Binding ProteinsBiomarkers, TumorDNA, NeoplasmLin28A protein, humanRNA-Binding ProteinsChinesegliomaLIN28Apolymorphismsusceptibility

Identifiers

PMID34468231
PMCPMC8414609
OpenAlexW3197205165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.